Ostenil tendon 1 injection 40mg / 2 ml
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.
Description OSTENIL® Tendon
OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in case of tendon affections.
OSTENIL® Tendon is a viscoelastic solution of sodium hyaluronate (sodium salt of hyaluronic acid) 2% (40mg/2ml) and mannitol 0.5% (10mg/2ml) for intra-articular injection.
Dosage and administration of OSTENIL® Tendon
Inject OSTENIL® TENDON around the affected tendon or into the affected tendon sheath once a week, for a total of 2 injections. Several tendons can be treated at the same time. Repeated treatments are possible if needed.
The contents and outer surface of the pre-filled syringe of OSTENIL® TENDON remain sterile as long as the sterile packaging remains intact. Remove the pre-filled syringe from the sterile package, unscrew the Luer-Lock closure from the syringe, attach a suitable needle (e.g. 25-27 G) and ensure that it is securely attached by twisting it slightly. Before injection, make sure to remove any air bubbles from the syringe.
Composition OSTENIL® Tendon
1 ml of isotonic solution contains 20.0 mg of sodium hyaluronate, as well as sodium chloride, monosodium phosphate, disodium phosphate, mannitol and water for injection.
Contraindications OSTENIL® Tendon:
Do not use OSTENIL® TENDON in case of known hypersensitivity to any of the components.
OSTENIL® Tendon Interactions:
To date, no data are available on the incompatibility of OSTENIL® TENDON with other products for use on tendons. Adverse reactions:
Following the use of OSTENIL® TENDON, local concomitant manifestations such as pain, warmth, hematoma, redness and swelling may occur.
When using OSTENIL® TENDON, special care should be taken in patients with known hypersensitivity to drugs. As with all invasive treatments, infection may occur in very rare cases. Therefore, general precautions related to peritendinous injections and injections into the synovial tendon sheath should be observed. OSTENIL® TENDON should be injected correctly into the synovial tendon sheath or around the injured tendon, if necessary under scopic control. Nerve damage and injections into blood vessels should be avoided. In the absence of clinical data on the use of OSTENIL® TENDON in children, pregnant or nursing women, and in cases of acute trauma, the administration of OSTENIL® TENDON is not recommended in these patients. Do not use if the pre-filled syringe or sterile packaging is damaged. Any unused solution immediately after opening should be discarded. Otherwise, sterility is no longer guaranteed, and this may be associated with a risk of infection. Store at a temperature between 2°C and 25°C. Do not use after the expiry date mentioned on the box. Keep out of reach of children.
Properties and mode of action:
A strong structure made of fibrous connective tissue, a tendon ensures the transmission of effort from the muscles to the bones and resistance to tension during muscle contraction. Tendons can be surrounded by different structures: for example retinacula, tendon synovial sheaths, peritendon, bursa. Excessive solicitation or inappropriate biomechanical stress can cause inflammation and/or degenerative changes in the tendons, leading to pain and loss of function. Lubricating the tendon may reduce pain, improve tendon function and reduce the possibility of adhesions.
Thanks to its lubricating and viscoelastic properties, OSTENIL® TENDON supports the sliding ability of the tendons as well as the physiological regeneration process. Furthermore, due to its macromolecular structure, OSTENIL® TENDON reduces the free passage of cells and molecules that promote inflammation through the tendon synovial sheath.
OSTENIL® TENDON is a transparent solution based on highly purified natural sodium hyaluronate, produced by fermentation and therefore containing no animal protein. OSTENIL® TENDON also contains mannitol, a free radical scavenger, which helps stabilize the sodium hyaluronate chains. Biocompatibility studies have shown OSTENIL® TENDON to be particularly well tolerated.
One OSTENIL® TENDON pre-filled syringe containing 40 mg/2.0 mL in sterile packaging.
Add Other Product These products may interest you
Indications: STRUCTUM is used in adults (over 15 years of age) for the treatment of pain and functional discomfort in osteoarthritis of the knee and hip. This drug has a slow onset of action, delayed by about 2 months, and its effect may persist after treatment has been stopped.
Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee
Sinovial® is indicated in cases of pain or reduced mobility in order to restore the physiological and rheological properties of arthritic joints.
SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.
The therapeutic indications are all types of painful gonarthrosis:
- Primary gonarthrosis (Kelgreen radiological stages I, II and III)
- Gonarthrosis and associated general factors:
- Ineffectiveness of usual treatments.
- Intolerance and/or contraindication to NSAIDs and/or analgesics.
- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).
- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.
- Early gonarthrosis in young patients.
- Gonarthrosis secondary to trauma and the aftermath of articular fractures.
Flector effigel is a medicine containing an anti-inflammatory and an analgesic, it is used in the short term local treatment, in adults and children over 15 years old, in case of benign trauma: sprain, strain, or contusion.
A cream to soothe and limit joint pain Designed to relieve lower back pain, this warming cream has anti-inflammatory and moisturizing properties. It provides a sensation of warmth that helps relax muscles and joints. Mobility improves day by day with regular application.
Indication : Sinovial® One is indicated in case of pain or limitations of mobility due to degenerative or post-traumatic affections or to alterations of the joint and tendons, in order to restore the physiological and rheological conditions of arthrosic joints.
1 pre-filled syringe of 2.5ml 50MG/2.5 ML of hyaluronic acid
Indications: Phytostandard of harpagophytum and willow Pileje is a food supplement to improve joint comfort.
The extracts of harpagophytum and willow are obtained through the patented Phytostandard® process known for its respect for the integrity of the plant's compounds.
Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.
COXARTHRUM is indicated to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid of the arthritic joint.
COXARTHRUM exerts its therapeutic effect by viscosupplementation, a process by which the physiological and rheological properties of the synovial fluid of the arthritic hip are improved.
COXARTHRUM is indicated for the symptomatic treatment of coxarthrosis by intra-articular injection. COXARTHRUM must be administered only intra-articularly under radio-guidance or by ultrasound and this by a specialist doctor, to relieve the pain associated with osteoarthritis of the hip.
Indication : Medicine indicated in the symptomatic treatment of osteoarthritis in particular of the hip and the knee. Chondrosulf contains chondroitin sulphate and is indicated for adults (over 15 years).